Harbour Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647 Hold
58
﹤0.01% 4317
2026
Q1
$810 Hold
58
﹤0.01% 4153
2025
Q4
$835 Sell
58
-489
-89% -$7.35K ﹤0.01% 3488
2025
Q3
$8.71K Sell
547
-31,792
-98% -$524K ﹤0.01% 2753
2025
Q2
$572K Sell
32,339
-663
-2% -$12.9K 0.01% 721
2025
Q1
$688K Buy
33,002
+32,944
+56,800% +$625K 0.02% 612
2024
Q4
$1.07K Hold
58
﹤0.01% 3155
2024
Q3
$1.14K Hold
58
﹤0.01% 3068
2024
Q2
$1.14K Sell
58
-62
-52% -$1.18K ﹤0.01% 2966
2024
Q1
$2.16K Sell
120
-81
-40% -$1.47K ﹤0.01% 2764
2023
Q4
$3.41K Buy
+201
New +$3.99K ﹤0.01% 2542

Other funds holding BTAL

Harbour Investments's BTAL Position: Q2 2026 in Review

Harbour Investments held its AGF US Market Neutral Anti-Beta Fund (BTAL) position steady in Q2 2026 at 58 shares worth $647. The position accounts for ﹤0.01% of the portfolio, ranked #4317.

Harbour Investments first reported a position in BTAL in Q4 2023 and has held it in 11 quarters since. The position peaked at $688K in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Harbour Investments held 58 shares of AGF US Market Neutral Anti-Beta Fund worth $647 as of Q2 2026.
  • Harbour Investments left its AGF US Market Neutral Anti-Beta Fund share count unchanged in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4317 holding.
  • Harbour Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 11 quarters since.
  • Harbour Investments's AGF US Market Neutral Anti-Beta Fund position peaked at $688K in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.